Neuroscience
Antidepressant
100%
Major Depressive Disorder
64%
Escitalopram
58%
Nortriptyline
51%
Gene Expression
15%
Depressive Disorder
13%
Genetic Variation
13%
Genome-Wide Association Study
13%
Serotonin Transporter
13%
Selective Serotonin Reuptake Inhibitor
12%
5-HTTLPR
11%
Cortisol
10%
Body Mass Index
9%
Serotonergic
9%
Tricyclic Antidepressant
9%
Single-Nucleotide Polymorphism
9%
Brain-Derived Neurotrophic Factor
9%
Antipsychotic
8%
Meta-Analysis
7%
Parkinson's Disease
6%
Behavior (Neuroscience)
6%
Cannabis
6%
Amygdala
6%
Drug Therapy
6%
Metabolic Pathway
6%
Treatment of Depression
6%
Cortisol Awakening Response
6%
Transcriptomics
6%
Cytochrome P450 2D6
5%
Cognitive Disorders
5%
Adverse Effect
5%
Genetic Marker
5%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
16%
Single Nucleotide Polymorphism
11%
Genome-Wide Association Study
10%
Genetic Variation
9%
Escitalopram
7%
Genetics
6%
Pharmacogenetics
6%
Gene Expression
6%
Pharmacogenetic Testing
5%
Single-Nucleotide Polymorphism
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
19%
Escitalopram
10%
Nortriptyline
9%
Pharmacogenetics
7%
Aripiprazole
6%
Major Depression
5%
